Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 23

Trial Status

Completed1
Recruiting1
Other3

Role Distribution

Principal Investigator2
Other Roles3
PI Rate40%

Activity Timeline

Clinical Trials (5)

NCT05827055Phase 2Active Not Recruiting
Proglumide and Chemotherapy for Metastatic Pancreatic Cancer
Metastatic Pancreatic Cancer
PrincipalinvestigatorStart date: 2024-01-31
NCT05558982Phase 2Active Not Recruiting
BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Metastatic Pancreatic Ductal Adenocarcinoma
StudychairStart date: 2023-08-16
NCT05661201Phase 1Recruiting
NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors
KRAS Mutation-Related TumorsSolid Tumor
StudychairStart date: 2023-04-12
NCT04005339Phase 2Active Not Recruiting
NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer
Advanced Biliary Tract Cancer
StudychairStart date: 2019-07-29
NCT03885284Phase 1Completed
Study of Proton Therapy in Adjuvant Pancreatic Cancer
Resected Pancreatic Adenocarcinoma
PrincipalinvestigatorStart date: 2019-07-15

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT05827055Phase 2PrincipalInvestigator

Proglumide and Chemotherapy for Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer
Active Not Recruiting
NCT05558982Phase 2StudyChair

BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Metastatic Pancreatic Ductal Adenocarcinoma
Active Not Recruiting
NCT05661201Phase 1StudyChair

NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors

KRAS Mutation-Related TumorsSolid Tumor
Recruiting
NCT04005339Phase 2StudyChair

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

Advanced Biliary Tract Cancer
Active Not Recruiting
NCT03885284Phase 1PrincipalInvestigator

Study of Proton Therapy in Adjuvant Pancreatic Cancer

Resected Pancreatic Adenocarcinoma
Completed

All 5 trials loaded